Jazz Pharmaceuticals (JAZZ) Cash & Equivalents Growth (3y) (2013 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | -51.77% |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | 24.73% |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | -28.55% |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | 13.33% |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | -16.07% |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | 21.66% |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | -8.88% |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 36.53% |
| 10 | Jazz Pharmaceuticals | 14.64 Bn | 12.79 Bn | 934.80 Mn | 16.45% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 16.45% |
| Dec 31, 2025 | 16.45% |
| Sep 30, 2025 | 16.47% |
| Jun 30, 2025 | 18.71% |
| Mar 31, 2025 | 55.96% |
| Dec 31, 2024 | 59.79% |
| Sep 30, 2024 | 48.91% |
| Jun 30, 2024 | 15.00% |
| Mar 31, 2024 | -11.71% |
| Dec 31, 2023 | 12.51% |
| Sep 30, 2023 | 21.65% |
| Jun 30, 2023 | 17.72% |
| Mar 31, 2023 | 18.51% |
| Dec 31, 2022 | 11.42% |
| Sep 30, 2022 | 1.82% |
| Jun 30, 2022 | 3.70% |
| Mar 31, 2022 | -3.57% |
| Dec 31, 2021 | 24.08% |
| Sep 30, 2021 | 10.42% |
| Jun 30, 2021 | 22.49% |
| Mar 31, 2021 | 66.65% |
| Dec 31, 2020 | 39.93% |
| Sep 30, 2020 | 43.21% |
| Jun 30, 2020 | 48.67% |
| Mar 31, 2020 | 26.45% |
| Dec 31, 2019 | 20.31% |
| Sep 30, 2019 | 29.45% |
| Jun 30, 2019 | -9.76% |
| Mar 31, 2019 | -17.63% |
| Dec 31, 2018 | -32.09% |
| Sep 30, 2018 | -20.65% |
| Jun 30, 2018 | -19.26% |
| Mar 31, 2018 | -16.65% |
| Dec 31, 2017 | -17.36% |
| Sep 30, 2017 | -23.98% |
| Jun 30, 2017 | -3.75% |
| Mar 31, 2017 | 12.17% |
| Dec 31, 2016 | -16.85% |
| Sep 30, 2016 | -14.60% |
| Jun 30, 2016 | 19.84% |
| Mar 31, 2016 | 29.56% |
| Dec 31, 2015 | 36.69% |
| Sep 30, 2015 | 73.94% |
| Jun 30, 2015 | 81.34% |
| Mar 31, 2015 | 66.14% |
| Dec 31, 2014 | 102.75% |
| Sep 30, 2014 | 78.44% |
| Jun 30, 2014 | 37.85% |
| Mar 31, 2014 | 55.76% |
| Dec 31, 2013 | 142.21% |
| Sep 30, 2013 | 195.30% |
| Jun 30, 2013 | 274.86% |